Palatin Technologies Inc. (PTN) stock rises during pre-market trading. What has been happening lately?

Palatin Technologies Inc. (NASDAQ: PTN) stock declined by 1.16% the last close whereas the PTN stock price gains by 3.91% in the pre-market trading session. Palatin is a pharmaceutical firm focused on creating first-in-class medications that target the melanocortin and natriuretic peptide receptor systems with targeted receptor-specific pharmaceutical candidates for illnesses with high unfulfilled medical […]

Palatin Technologies Inc. (NASDAQ: PTN) stock surges during after-market trading. Let’s find out why?

Palatin Technologies Inc. (NASDAQ: PTN) stock gained by 23.49% at the last close while the PTN stock price rises by 0.18% in the after-market trading session. Palatin is a biopharmaceutical firm focused on creating first-in-class medications that target the melanocortin and natriuretic peptide receptor systems. The targeted, receptor-specific pharmaceutical candidates developed by PTN are used […]